Efficacy of RyR2 inhibitor EL20 in induced pluripotent stem cell‐derived cardiomyocytes from a patient with catecholaminergic polymorphic ventricular tachycardia-Reference-Cited by-同舟云学术

Efficacy of RyR2 inhibitor EL20 in induced pluripotent stem cell‐derived cardiomyocytes from a patient with catecholaminergic polymorphic ventricular tachycardia

Published:2021-06-10 Issue: Volume: Page:
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J Cell Mol Med

Author:

Word Tarah A.¹,Quick Ann P.²,Miyake Christina Y.¹²,Shak Mayra K.¹,Pan Xiaolu¹,Kim Jean J.³,Allen Hugh D.³,Sibrian‐Vazquez Martha⁴,Strongin Robert M.⁵,Landstrom Andrew P.⁶⁷^ORCID,Wehrens Xander H. T.¹²⁸⁹¹⁰^ORCID

Affiliation:

1. Department of Molecular Physiology & Biophysics Cardiovascular Research Institute Baylor College of Medicine Houston TX USA

2. Section of Cardiology Department of Pediatrics Baylor College of Medicine Houston TX USA

3. Department of Molecular & Cellular Biology Stem Cells and Regenerative Medicine Center Baylor College of Medicine Houston TX USA

4. Elex Biotech Inc Portland OR USA

5. Department of Chemistry Portland State University Portland OR USA

6. Department of Pediatrics Division of Cardiology Duke University School of Medicine Durham NC USA

7. Department of Cell Biology Duke University School of Medicine Durham NC USA

8. Department of Medicine Section of Cardiology Baylor College of Medicine Houston TX USA

9. Department of Neuroscience Section of Cardiology Baylor College of Medicine Houston TX USA

10. Center for Space Medicine Baylor College of Medicine Houston TX USA

Funder

Saving Tiny Hearts Society

National Heart, Lung, and Blood Institute

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.16521

Reference31 articles.

1. FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise‐induced sudden cardiac death;Wehrens XH;Cell,2003

2. Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia;Laitinen PJ;Circulation,2001

3. Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak;Lehnart SE;Circulation,2004

4. Cardiac ryanodine receptor function and regulation in heart disease;Lehnart SE;Ann N Y Acad Scin,2004

5. Clinical challenges in catecholaminergic polymorphic ventricular tachycardia;Imberti JF;Heart Lung Circ,2016

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stem cell models of inherited arrhythmias;Nature Cardiovascular Research;2024-03-21

2. iPSC-cardiomyocytes in the preclinical prediction of candidate pharmaceutical toxicity;Frontiers in Pharmacology;2024-02-28

3. Screening for Novel Type 2 Ryanodine Receptor Inhibitors by Endoplasmic Reticulum Ca²⁺Monitoring;Molecular Pharmacology;2023-09-07

4. Catecholaminergic Polymorphic Ventricular Tachycardia;Cardiac Electrophysiology Clinics;2023-09

5. Screening for novel RyR2 inhibitors by ER Ca²⁺monitoring;2023-08-22